A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis

Clinical trial NCT01382212 · COMPLETED

Trial details

NCT number: NCT01382212
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

End-Stage Renal Disease Secondary Hyperparathyroidism

Start date: 2011-10-01
Primary completion: 2015-04-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.